The effect of a new slow-release, long-acting somatostatin analogue, lanreotide, in acromegaly

MLA

Pat Kendall-Taylor, et al. “The Effect of a New Slow-Release, Long-Acting Somatostatin Analogue, Lanreotide, in Acromegaly.” Clinical Endocrinology, vol. 45, Oct. 1996, pp. 415–21. EBSCOhost, https://doi.org/10.1046/j.1365-2265.1996.8270836.x.

APA

Pat Kendall-Taylor, Jan Gebbie, & M. Al-Maskari. (1996). The effect of a new slow-release, long-acting somatostatin analogue, lanreotide, in acromegaly. Clinical Endocrinology, 45, 415–421. https://doi.org/10.1046/j.1365-2265.1996.8270836.x

Chicago

Pat Kendall-Taylor, Jan Gebbie, and M. Al-Maskari. 1996. “The Effect of a New Slow-Release, Long-Acting Somatostatin Analogue, Lanreotide, in Acromegaly.” Clinical Endocrinology 45 (October): 415–21. doi:10.1046/j.1365-2265.1996.8270836.x.